Oxfendazole Development Group
Organization Overview & Grant Funding Intelligence
Oxfendazole Development Group is an active 501(c)(3) public charity headquartered in Blue Bell, Pennsylvania (EIN: 81-1547477), operating within the Medical Research sector (NTEE code H80). Recognized as tax-exempt by the IRS in Jul 2016, the organization reports $9K in annual revenue and $100K in total balance sheet assets on its most recent public Form 990 filing.
According to public IRS Form 990 and Form 990-PF grant disclosures, Oxfendazole Development Group has received 4 documented institutional foundation grants totaling $1.7M, including grant awards from Amazonsmile Foundation, Silicon Valley Community Foundation, and Centre for Effective Altruism USA INC. These investments support ongoing operations, program initiatives, and community services centered in Pennsylvania.
Based on its mission classification and geographic presence in Blue Bell, NPO Grant has matched Oxfendazole Development Group with 7,873+ institutional foundations currently deploying capital to medical research organizations in Pennsylvania. Nonprofits tracking these peer funding relationships can monitor grant schedules, median award amounts, and unsolicited inquiry policies.
Documented Foundation Grants Awarded to Oxfendazole Development Group
“DEVELOP THE DEWORMING MEDICINE FOR USE AGAINST HUMAN DWELLING PARASITIC WORMS”
Active Foundations Funding Similar Organizations in Pennsylvania
The following active grantmakers regularly award grants to Medical Research nonprofits in Pennsylvania. Direct program officer contact lines and submission guidelines are unlocked inside your workspace.
Frequently Asked Questions
Is Oxfendazole Development Group a tax-exempt 501(c)(3) nonprofit?
Yes. Oxfendazole Development Group (EIN 81-1547477) holds active Public Charity — 509(a)(1) status recognized by the Internal Revenue Service (IRS determination dated Jul 2016). Contributions to the organization are tax-deductible under Internal Revenue Code Section 170.
What is Oxfendazole Development Group's EIN and location?
Oxfendazole Development Group's Employer Identification Number (EIN) is 81-1547477. The organization is registered in Blue Bell, Pennsylvania 19422-1411, categorized under NTEE classification Medical Research (H80).
Which foundations have awarded grants to Oxfendazole Development Group?
Public IRS filings record 4 documented foundation grants awarded to Oxfendazole Development Group totaling $1.7M, including awards from Amazonsmile Foundation, Silicon Valley Community Foundation, and Centre for Effective Altruism USA INC.
How can Oxfendazole Development Group find additional foundation grants in Pennsylvania?
Oxfendazole Development Group can claim its free NPO Grant workspace to review all 7,873+ matched grantmakers currently funding medical research initiatives in Pennsylvania, access direct program officer contact lines, and generate tailored Letter of Inquiry (LOI) starter drafts.
Is This Your Organization? See Who Funds Nonprofits Like Yours
Create your free account to unlock all foundations funding Oxfendazole Development Group's mission in Pennsylvania, see program officer contacts, and generate tailored LOI drafts.